GLP-1 receptor agonists show promise in treating substance use disorders
A systematic review reveals that GLP-1 receptor agonists may help reduce certain substance use disorders, but findings are inconsistent due ...
A systematic review reveals that GLP-1 receptor agonists may help reduce certain substance use disorders, but findings are inconsistent due ...
Former President Donald Trump claimed at a recent campaign rally that more than 300,000 Americans are dying each year from ...
A new study, out now in Drug and Alcohol Dependence, that details trends among psychiatric hospitalizations between 2015-2019 finds that ...
Opioid medications offer people relief from debilitating pain, but these drugs come with dangers: the risk for addiction, miserable withdrawal ...
Marshall University was awarded a $3.3 million grant (#R01DA057931) from the National Institute on Drug Abuse (NIDA) to examine the ...
A new analysis revealed the frequency of potentially lethal substances, such as fentanyl and xylazine, in counterfeit pills that had ...
One January morning in 2021, Carol Rosen took a standard treatment for metastatic breast cancer. Three gruesome weeks later, she ...
The public health toll from bereavement is well-documented in the medical literature, with bereaved persons at greater risk for many ...
What question were you investigating? Despite elevated risk for substance use disorder and overdose death in the homeless population, benzodiazepine ...
Pain affects the lives of millions of Americans every day and improving pain care and the lives of patients with ...
Sepoy.net is a perfect place for people who want daily updates on news related to business, technology, entertainment, health, cryptocurrency etc.
Contact: hello@sepoy.net
© 2023 Sepoy.net